DiaMedica Therapeutics Inc. (DMAC)
NASDAQ·Healthcare·Biotechnology
$6.39
-3.77%
Mkt Cap $362.90M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
Implied Upside
+30.4%
Consensus $8.33 vs current $6.39
NASDAQ·Healthcare·Biotechnology
$6.39
-3.77%
Mkt Cap $362.90M
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
+30.4%
Consensus $8.33 vs current $6.39